{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG" in comments (approximate match)
Status:
Investigational
Source:
INN:zaltenibart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:pegtarazimod [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03205995: Phase 3 Interventional Recruiting Thrombotic Microangiopathies
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:nivatrotamab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01152788: Phase 2 Interventional Completed Melanoma
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT03395704: Phase 2 Interventional Completed Hereditary Hemochromatosis
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:zelpultide alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:quisovalimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:erfonrilimab [INN]
Source URL:
Class:
PROTEIN